Celldex Therapeutics, Inc.
CLDX· Nasdaq
Celldex Therapeutics, Inc.
- Last sale
- Oct 2, 2026 · -1.60%
- Market cap
- $2.49B
- 78.53M shares
- Filings
- 1,025
Price
Oct 2, 2026 · IEX last sale
IEX last saleClose of record
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $1,545,000 | reported | |
| FY 2024 | 2024-12-31 | $7,020,000 | reported | |
| FY 2023 | 2023-12-31 | $6,883,000 | reported | |
| FY 2022 | 2022-12-31 | $2,357,000 | reported | |
| FY 2021 | 2021-12-31 | $4,651,000 | reported | |
| FY 2020 | 2020-12-31 | $7,418,000 | reported | |
| FY 2019 | 2019-12-31 | $3,573,000 | reported | |
| FY 2018 | 2018-12-31 | $9,538,000 | reported | |
| FY 2017 | 2017-12-31 | $12,743,000 | reported | |
| FY 2016 | 2016-12-31 | $6,786,000 | reported | |
| FY 2015 | 2015-12-31 | $5,480,000 | reported | |
| FY 2014 | 2014-12-31 | $3,586,000 | reported |
Celldex Therapeutics, Inc. · CIK 744218 · Engraved from SEC EDGAR
